Found: 32
Select item for more details and to access through your institution.
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-023-03619-9
- By:
- Publication type:
- Article
Severe dysautonomia as a manifestation of neurotoxicity after CAR‐T cell therapy for diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. E146, doi. 10.1002/ajh.25794
- By:
- Publication type:
- Article
Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. E273, doi. 10.1002/ajh.25591
- By:
- Publication type:
- Article
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 8, p. E216, doi. 10.1002/ajh.25515
- By:
- Publication type:
- Article
Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 3, p. 331, doi. 10.1002/ajh.21950
- By:
- Publication type:
- Article
A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2149, doi. 10.3390/cancers16112149
- By:
- Publication type:
- Article
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e716, doi. 10.1016/j.clml.2022.03.013
- By:
- Publication type:
- Article
Phase 1 study of lenalidomide plus dose‐adjusted EPOCH‐R in patients with aggressive B‐cell lymphomas with deregulated MYC and BCL2.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 11, p. 1830, doi. 10.1002/cncr.31877
- By:
- Publication type:
- Article
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center study.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 1064, doi. 10.1002/cncr.29160
- By:
- Publication type:
- Article
Life-threatening autoimmune hemolytic anemia in a patient with the acquired immune deficiency syndrome.
- Published in:
- Transfusion, 1988, v. 28, n. 2, p. 190, doi. 10.1046/j.1537-2995.1988.28288179030.x
- By:
- Publication type:
- Article
Treatment and outcomes of post-transplant lymphoproliferative disease: A single institution study.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 3, p. 208, doi. 10.1002/ajh.20795
- By:
- Publication type:
- Article
Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: Two case reports and a review of literature.
- Published in:
- American Journal of Hematology, 2004, v. 77, n. 1, p. 55, doi. 10.1002/ajh.20151
- By:
- Publication type:
- Article
Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 1997, v. 54, n. 4, p. 332, doi. 10.1002/(SICI)1096-8652(199704)54:4<332::AID-AJH14>3.0.CO;2-D
- By:
- Publication type:
- Article
Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: A cost analysis.
- Published in:
- American Journal of Hematology, 1995, v. 48, n. 2, p. 108, doi. 10.1002/ajh.2830480208
- By:
- Publication type:
- Article
Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue.
- Published in:
- American Journal of Hematology, 1992, v. 40, n. 2, p. 86, doi. 10.1002/ajh.2830400203
- By:
- Publication type:
- Article
Hemopoietic Growth Factors: A Review.
- Published in:
- Journal of Clinical Pharmacology, 1992, v. 32, n. 6, p. 486, doi. 10.1177/009127009203200602
- By:
- Publication type:
- Article
Neurotoxicity of Bortezomib Therapy in Multiple Myeloma: A Single-center Experience and Review of the Literature.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 5, p. 1042, doi. 10.1002/cncr.22921
- By:
- Publication type:
- Article
Plasma exchange and rituximab treatment for lenalidomide-associated cold agglutinin disease.
- Published in:
- Transfusion, 2012, v. 52, n. 11, p. 2432, doi. 10.1111/j.1537-2995.2012.03608.x
- By:
- Publication type:
- Article
Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 737, doi. 10.3390/vaccines9070737
- By:
- Publication type:
- Article
Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 112, doi. 10.1093/neuonc/noaa183
- By:
- Publication type:
- Article
Toxoplasma‐induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 2, p. 1, doi. 10.1111/tid.13242
- By:
- Publication type:
- Article
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 8, p. 914, doi. 10.1038/nm.3910
- By:
- Publication type:
- Article
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
- Published in:
- Nature Medicine, 2005, v. 11, n. 11, p. 1230, doi. 10.1038/nm1310
- By:
- Publication type:
- Article
Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for Induction and Stem Cell Mobilization in Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 210
- By:
- Publication type:
- Article
Deep dissection of the antiviral immune profile of patients with COVID-19.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02852-1
- By:
- Publication type:
- Article
Lenalidomide-induced eosinophilic pneumonia.
- Published in:
- Respirology Case Reports, 2017, v. 5, n. 4, p. n/a, doi. 10.1002/rcr2.233
- By:
- Publication type:
- Article
Survival analysis with functional covariates for partial follow-up studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141906
- By:
- Publication type:
- Article
Detection of CD4<sup>+</sup> T-cell antibodies in a patient with idiopathic CD4<sup>+</sup> T lymphocytopenia and cryptococcal meningitis.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 1, p. 133, doi. 10.1111/j.1365-2141.2007.06781.x
- By:
- Publication type:
- Article
Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2000, v. 111, n. 2, p. 662, doi. 10.1046/j.1365-2141.2000.02363.x
- By:
- Publication type:
- Article